Pharmafile Logo
Pharmafocus logo
Advanced Search
opdivo_1

FDA accepts another Opdivo indication for priority review

October 24, 2016
Sales and Marketing BMS, Bristol-Myers Squibb, FDA, opdivo

The FDA has accepted a supplemental Biologics License Application (sBLA) for Bristol-Myers Squibb’s Opdivo for treatment of locally advanced unresectable …

News
merck_incweb

MSD’s Keytruda early success ends trial early

October 24, 2016
Sales and Marketing MSD, Merck, Roche, keytruda, opdivo, tecentriq

MSD, known as Merck in the US, ended their Phase III trial of Keytruda for treatment of advanced urothelial cancer …

News

Phase III depression trial success for Alkermes

October 24, 2016
Research and Development, Sales and Marketing ALKS 5461, Alkermes, major depressive disorder

Biopharma company Alkermes has announced the success of its ALKS 5461 treatment in a Phase III study for the treatment …

News
gsk_boronia_australia

GSK applies for FDA approval for shingles vaccine

October 24, 2016
Sales and Marketing GSK, GlaxoSmithKline, Vaccine, chickenpox, shingles

GlaxoSmithKlien, the UK’s biggest drugmaker, is seeking approval from the FDA for a shingles (herpes zoster) vaccine. The vaccine would …

News
top_ten_1

Top Ten articles in the pharma industry this week

October 21, 2016
Medical Communications biggest stories, news, week, weekly

This week has seen a few big collaboration and partnerships occur, whilst there have been some major movements within immunotherapy …

News

Merck KGaA and Pfizer team up with Debiopharm in lung cancer treatment

October 21, 2016
Medical Communications Debiopharm, Merck KGaA, NSCLC, Pfizer, lung cancer

Debiopharm International, the Swiss-based global biopharmaceutical group of five companies, announced that it would be entering into an agreement with …

News
gilead-sciences

Gilead’s drug boosted by positive Phase II trials and aims to move forward

October 21, 2016
Medical Communications Gilead, Gilead Sciences, clinical trials, fatty liver disease

Gilead Sciences has announced positive results from three Phase II studies upon their drug GS-4997, otherwise known as selonsertib. The …

News

UK Government announces deep cuts to pharmacy funding

October 21, 2016
Medical Communications Conservative, NHS, UK, government, pharmacy

The Department Health announced that it wanted to reduce the £2.8 billion a year funding for pharmacies by 7%, leading …

News
allergan

FDA advisory committee approves of Allergan’s night-time urination medicine

October 20, 2016
Medical Communications Allergan, FDA, Night-time urination, sleep, urination

The FDA’s advisory committee ruled, in a 14-4 vote, that Allergan’s experimental nocturnal urination medication, SER120, in favour of the …

News
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …

News
sunset-flag-america-fields

The Pharmafocus guide to the US presidential election 2016

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing US election, feature

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …

Feature
novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …

News
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …

News

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …

News
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …

News

Specialist Clinical Trials Equipment Supplier Woodley Equipment Company Exhibiting at OCT Southern California

October 19, 2016

Woodley Equipment is exhibiting at Outsourcing in Clinical Trials Southern California taking place on 26th and 27th October 2016 at …

News
Press release
vaccine3a-062568e

Sun Pharma partners with ICGEB to develop dengue vaccine

October 19, 2016
Research and Development Vaccine, dengue, icgeb, sun pharmaceutical

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …

News
lilly_corporate_hq

Lilly announces plan to expand global access to health care

October 19, 2016
Research and Development Eli Lilly, Lilly 30x30, global health

Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …

News

Roche’s immunotherapy cancer drug given FDA approval

October 19, 2016
Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer

Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …

News

Recipharm to open largest Nordic GLP bioanalysis lab

October 19, 2016
Manufacturing and Production, Research and Development Recipharm, Sweden, expansion

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026